This inventor holds 1 USPTO granted patent. Top assignee: Locus Genex Oy. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Sari Ylatupa: Innovator in Reactive Condition Diagnosis
Introduction
Sari Ylatupa is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of medical diagnostics, particularly in the detection of reactive conditions. Her innovative approach has the potential to improve the diagnosis of serious health issues, such as malignant tumors.
Latest Patents
Sari Ylatupa holds a patent for a method that focuses on the detection of reactive conditions. This invention relates specifically to the diagnosis of malignant tumors. The method involves determining the amount of cellular fibronectin in a body fluid, where an elevated amount serves as a marker for a reactive condition. This technique is especially suitable for diagnosing carcinomas, including colon carcinoma. She has 1 patent to her name.
Career Highlights
Sari Ylatupa is associated with Locus Genex Oy, a company that specializes in innovative solutions for genetic diagnostics. Her work at the company has been instrumental in advancing diagnostic methods that can lead to earlier detection and treatment of cancers.
Collaborations
Sari collaborates with notable colleagues, including Ismo Virtanen and Paul Partanen. Their combined expertise enhances the research and development efforts at Locus Genex Oy.
Conclusion
Sari Ylatupa's contributions to the field of medical diagnostics exemplify the impact of innovation in healthcare. Her patented method for detecting reactive conditions represents a significant advancement in the diagnosis of malignant tumors.